Joining forces to fight cancer

You can make a difference in the lives of patients while enjoying an enjoyable evening.

This event is over. Thanks for your generosity!

I’m subscribing to the newsletter to keep up to date!

By subscribing, you agree to our Privacy Policy.

The Annuel Fodago invites you to enjoy privately imported wines!

Participate in the Annuel Fodago, an opportunity to savour some privately imported wines, in aid of Fondation Hôpital Charles-LeMoyne and its mission to support the Hospital’s patients!

On November 15, 2023, the firm Fortier D’Amour Goyette will be holding a benefit evening from 5:30 p.m. to 8:30 p.m. at Dock619 in Longueuil.

When you register and participate in the Annuel Fodago, you’re doing a lot more than tasting exquisite wines. You’re actively supporting the fight against cancer. You’re offering hope to patients who battle the disease each and every day.

Your generosity will contribute to funding leading-edge treatments, personalized care and precious support services for patients and their families. All of the profits raised will go to improving the lives of patients at the Hospital.

Spaces are limited, so reserve your ticket today for this solidarity evening.

Yes! I want to support the patients at Hôpital Charles-Le Moyne.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

© 2024 Fondation Hôpital Charles-LeMoyne. Tous droits réservés.

No d’organisme de bienfaisance : 13460 7936 RR0001

You have the greatest impact when you give every month!

Small or big, every gesture makes a difference

Honour the memory of a loved one.

© 2024 Fondation Hôpital Charles-LeMoyne. All rights reserved.

Charitable Registration Number: 13460 7936 RR0001

You have the greatest impact when you give every month!

Small or big, every gesture makes a difference

Honour the memory of a loved one.